首页> 外文期刊>Journal of Microbiology and Infectious Diseases >Abstract - Acinetobacter baumannii isolates in a tertiary care hospital: Antimicrobial resistance and clinical significance
【24h】

Abstract - Acinetobacter baumannii isolates in a tertiary care hospital: Antimicrobial resistance and clinical significance

机译:摘要-鲍曼不动杆菌在三级医院的分离:抗菌素耐药性及其临床意义

获取原文
       

摘要

Objectives To carry out a retrospective study on Acinetobacter baumannii isolates from various clinical samples in a tertiary care hospital in India and analyze its epidemiology, antibiotic susceptibility patterns, pathogenic potential and nosocomial status. Materials and methods The clinical specimens over a period of 14 months from December 2008 to January 2010 were analyzed and the A.baumannii isolates obtained by an automated identification system (Vitek 2 Compact) were segregated for further study. Their antibiograms were studied and a clinical correlation was made to assess their pathogenic status and mode of acquisition. Further, the nosocomial infections acquired during this period were studied and the contribution made by A.baumannii was calculated to assess its nosocomial status. Results A.baumannii was isolated in 155 samples out of 1632 gram negative isolates (9.4% prevalence) from the entire hospital. Maximum isolates were from respiratory secretions (57.4%) followed by blood (23.8%). Prevalence of A.baumannii rose to 22.7% (119 out of 525) in intensive care unit (ICU) and 65 isolates (54.6%) proved to be pathogenic. A.baumannii contributed to 30.4% ventilator associated pneumonia, 35.2% Catheter Associated Blood Stream Infections, 12.5% Surgical Site Infections and 2.94% Catheter Associated Urinary Tract Infections. Overall resistance of A.baumannii towards carbapenems was 90% from all hospital isolates. ICU isolates showed higher resistance (93.2%) as compared to Inpatient Department (82.7%) and Out-patient Department (57.1%). Conclusion In this study, A.baumannii isolates showed a pathogenic potential of around 54.6% and a majority were found to be carbapenem resistant. We must be cognizant of the fact that all A.baumannii isolations doesn’t necessarily mean infection and antibiotics should only be given in clinically proven infections. J Microbiol Infect Dis 2012; 2(2) 57-63  .
机译:目的对印度一家三级医院的各种临床样本中的鲍曼不动杆菌进行回顾性研究,并分析其流行病学,抗生素敏感性模式,致病潜力和医院状况。材料和方法分析了从2008年12月至2010年1月的14个月内的临床标本,并分离了通过自动识别系统(Vitek 2 Compact)获得的鲍曼不动杆菌分离株,以进行进一步研究。对他们的抗菌素进行了研究,并进行了临床相关性评估其致病状态和获得方式。此外,对在此期间获得的医院感染进行了研究,并计算了鲍曼不动杆菌的贡献以评估其医院状况。结果从整个医院的1632克阴性分离株(占9.4%的患病率)中的155个样品中分离出鲍曼不动杆菌。最大的分离物来自呼吸道分泌物(57.4%),其次是血液(23.8%)。重症监护病房(ICU)中鲍曼不动杆菌的患病率升至22.7%(525个中的119个),并且65个分离株(54.6%)被证明是致病的。鲍曼不动杆菌导致30.4%的呼吸机相关性肺炎,35.2%的导管相关的血流感染,12.5%的手术部位感染和2.94%的导管相关的尿路感染。所有医院分离株中鲍曼不动杆菌对碳青霉烯类药物的总体耐药性为90%。与住院科(82.7%)和门诊科(57.1%)相比,ICU分离株显示出更高的耐药性(93.2%)。结论在这项研究中,鲍曼不动杆菌的分离株显示出约54.6%的致病性,并且大多数对碳青霉烯有抗性。我们必须意识到以下事实:所有鲍曼不动杆菌的分离并不一定意味着感染,而抗生素仅应在临床证明的感染中使用。 J微生物感染Dis 2012; 2(2)57-63。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号